Skip to main content
SpringerLink
Log in

Risk of angioedema with sacubitril/valsartan versus ACE inhibitors and ARBs

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Eworuke E, et al. Comparative Risk of Angioedema With Sacubitril-Valsartan vs Renin-Angiotensin-Aldosterone Inhibitors. Journal of the American College of Cardiology 81: 321-331, No. 4, 31 Jan 2023. Available from: URL: http://doi.org/10.1016/j.jacc.2022.10.033

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Risk of angioedema with sacubitril/valsartan versus ACE inhibitors and ARBs. Reactions Weekly 1942, 11 (2023). https://doi.org/10.1007/s40278-023-32620-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-32620-6

Search

Navigation